Skip to content

LENSAR, Inc. LNSR Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Staar Surgical logo
Staar SurgicalSTAA
$170K-54.8%
Bausch + Lomb logo
Bausch + LombBLCO
$2M
Schering-Plough logo
Schering-PloughSGP
$55K-45.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$148K
Lightpath Technologies logo
Lightpath TechnologiesLPTH
$57.45M
nLIGHT, Inc. logo
nLIGHT, Inc.LASR
$191.28M

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Reported directly by LENSAR, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s stock issuance proceeds?
LENSAR, Inc. (LNSR) reported stock issuance proceeds of $15K in Q1 2026.
How has LENSAR, Inc.'s stock issuance proceeds changed year-over-year?
LENSAR, Inc.'s stock issuance proceeds decreased by 28.6% year-over-year, from $21K to $15K.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.